Jeremie Abtan1,2, P Gabriel Steg1,2,3. Show Affiliations » 1. DHU (Département Hospitalo-Universitaire)-FIRE (Fibrosis, Inflammation, REmodelling), Hôpital Bichat, AP-HP (Assistance Publique-Hôpitaux de Paris), Université Paris-Diderot, Sorbonne-Paris Cité, Paris France. 2. FACT (French Alliance for Cardiovascular clinical Trials), an F-CRIN network, INSERM U-1148, Paris, France. 3. NLHI, ICMS, Royal Brompton Hospital, Imperial College, London, UK.
Abstract
Entities: Gene
Mesh： See more » AngioplastyCoronary AngiographyHumansPercutaneous Coronary InterventionPlatelet Aggregation InhibitorsPurinergic P2Y Receptor AntagonistsRegistriesST Elevation Myocardial InfarctionSweden
Substances： See more » Platelet Aggregation InhibitorsPurinergic P2Y Receptor Antagonists
Year: 2019 PMID： 30851044 DOI： 10.1093/eurheartj/ehz058
Source DB: PubMed Journal: Eur Heart J ISSN： 0195-668X Impact factor: 29.983